Bortezomib Alpha-Medical 3,5 mg prašak za otopinu za injekciju
Name | Bortezomib Alpha-Medical 3,5 mg prašak za otopinu za injekciju |
---|---|
Marketing Authorisation Number | HR-H-781716538 |
Active Substance | bortezomib |
Composition | svaka bočica sadrži 3,5 mg bortezomiba (u obliku estera boronatne kiseline i manitola) |
Pharmaceutical Form | prašak za otopinu za injekciju |
Packaging [MA Number for Packaging] | 1 bočica s praškom, u kutiji [HR-H-781716538-01] |
Manufacturer | PharmIdea SIA, Olaine, Latvija |
Marketing Authorisation Holder | Alpha-Medical d.o.o., Dragutina Golika 36, Zagreb, Hrvatska |
Marketing Authorisation Date | 24.01.2020 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/19-02/232 |
Registration Number | 381-12-01/70-20-03 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | L01XG01 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |
Educational materials for healthcare professionals |
Brošura s uputstvima o pripremi, doziranju i primjeni, verzija 3 Grafikon sheme liječenja, verzija 2 Pomična mjerka s uputama za doziranje, verzija 2 Poster s uputstvima za pripremu lijeka, verzija 3 |